Side-by-side comparison of AI visibility scores, market position, and capabilities
Embedded microcontroller leader (PIC, AVR, ARM MCUs) with $7.6B FY2024 revenue; deep inventory correction 2024-2025 after 46% revenue decline from peak; Atmel ($3.56B) and Microsemi ($8.35B) acquisitions.
Microchip Technology is a leading provider of microcontroller, digital signal controller, and analog semiconductor solutions for embedded control applications, founded in 1989 when Steve Sanghi led a management buyout of General Instrument's Microelectronics Division in Chandler, Arizona, where the company remains headquartered and trades on Nasdaq (MCHP). The company generated approximately $7.6 billion in net sales for fiscal year 2024 (ending March 31, 2024) under CEO Ganesh Moorthy, who succeeded Sanghi (who remains Executive Chair) in 2021. Microchip Technology has built one of the broadest microcontroller portfolios in the semiconductor industry through strategic acquisitions: the 2016 acquisition of Atmel ($3.56B) added AVR and SAM ARM-based microcontrollers, and the 2018 acquisition of Microsemi ($8.35B) added FPGAs, application-specific integrated circuits, timing products, and defense/aerospace-grade semiconductors that expanded Microchip's total addressable market substantially.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.